MassRoots Partners with Whoopi & Maya as Part of Multi-State Expansion Strategy

MassRoots, Inc. (MSRT), a leading technology platform for medical cannabis patients and businesses, is pleased to announce it has partnered with Whoopi & Maya, a medical cannabis product company founded by Whoopi Goldberg and Maya Elisabeth, to promote their expansion plans, which are expected in the coming months.

“We are thrilled with the reception Whoopi & Maya has gotten in our first year in California and women have been reaching out to us from all over asking when they’ll be able to get their hands on them, too,” stated Whoopi Goldberg, co-founder of Whoopi & Maya. “We’re excited to be working with an industry leader like MassRoots to get the word out and help more women find relief from pain and menstrual discomfort.”

“Whoopi & Maya represents the next generation of cannabis products – focused on quality and geared towards mainstream consumers,” stated MassRoots CEO Isaac Dietrich. “We’re excited to welcome them to the one million-user strong MassRoots community and help expand their market share in the rapidly growing medical cannabis industry.”

About Whoopi & Maya
Whoopi & Maya was launched in 2016 by Whoopi Goldberg and award-winning edibles maker Maya Elisabeth, founder of Om Edibles and winner of nine High Times Cannabis Cup awards.  The California-based medical marijuana company’s initial offerings included a signature line of herbal medical cannabis products, formulated to provide relief for women experiencing menstrual cramps and discomfort, including Raw sipping chocolate, THC-infused tincture, THC-infused bath soak and topical rub for localized pain.  One year later, Whoopi & Maya products are available in over 300 dispensaries, becoming one of the fastest growing brands in California, with plans to announce line extensions and regional expansions shortly.  Learn more at www.WhoopiandMaya.com.

About MassRoots
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

To view the original version on PR Newswire, visit:https://www.prnewswire.com/news-releases/massroots-partners-with-whoopi–maya-as-part-of-multi-state-expansion-strategy-300442608.html


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$HEMP Gives Report on Senate Hemp Cultivation Bill

Hemp, Inc. Reports on Senate Bill Filed to Legalize Hemp Cultivation in…

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGODF) Signs Agreement to Acquire Leading European CBD Company HemPoland

The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company…

$CTCO Update on Research Report by SeeThruEquity

UPDATE – Peak Pharmaceuticals Receives Favorable Research Report by SeeThruEquity BOULDER, CO–(Marketwired…

InMed Pharmaceuticals Inc. (IMLFF) Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D…